Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)

Clinical trial NCT00365378 · COMPLETED

Trial details

NCT number: NCT00365378
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HPV 16 Infection

Start date: 1999-09-01
Primary completion: 2004-03-01
Enrollment: 2409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.